精神科医 : 臨床および治療ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Using a Clinical Formulation to Understand Psychological Distress in People Affected by Huntington`s Disease: A Descriptive, Evidence-Based Model

Ziad Kronfol

Huntington`s disease (HD) is an inherited, life-limiting neurodegenerative condition. People with HD experience changes in cognitive motor and emotional functioning, and can also mainly at later stages exhibit behaviours that professionals and carers might find distressing such as hitting others, throwing objects, swearing or making inappropriate comments. While clinical formulation (an individualised approach used by mental health professionals to describe an individual`s difficulties) is a helpful tool to conceptualise patients` wellbeing, a specific formulation framework has not yet been developed for HD. However, evidence has shown that formulation can help guide clinical interventions and increase consistency of approach across multi-disciplinary teams, refine risk management and improve staff or carers` empathic skills and understanding of complex presentations. As a consequence, this paper proposes a new clinical formulation model for understanding distress among people with HD, based on a bio psychosocial framework [1].